Loek de Jong

10PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)ChemotherapyTumour immunologyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 02, 2025
Mitigating subtherapeutic cabozantinib exposure after prior mitotane therapy in adrenocortical carcinoma: Pharmacological boosting with cobicistat.

Annemieke M Peters van Ton, Nielka P van Erp, Annenienke C van de Ven

|Nov 21, 2024
Patients in Clinical Trials are Sub-Optimally Protected for Drug-Drug Interactions: A Call for Action.

David Burger, Loek de Jong, Daphne van Dijk

|Jun 10, 2023
Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant?

Eline L Giraud, Loek A W de Jong, Erik van den Hombergh

|Mar 09, 2023
Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer.

Loek A W de Jong, Marie Lambert, Nielka P van Erp

|Jan 21, 2021
Pressurized Intraperitoneal Aerosol Chemotherapy: The Road from Promise to Proof.

Loek A W de Jong, Nielka P van Erp, Lana Bijelic

Pageof 2